miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression

Cystic fibrosis (CF) is one of the most common lethal genetic diseases in which the role of microRNAs has yet to be explored. Predicted to be regulated by miR-126, TOM1 (target of Myb1) has been shown to interact with Toll-interacting protein, forming a complex to regulate endosomal trafficking of ubiquitinated proteins. TOM1 has also been proposed as a negative regulator of IL-1β and TNF-α–induced signaling pathways. MiR-126 is highly expressed in the lung, and we now show for the first time differential expression of miR-126 in CF versus non-CF airway epithelial cells both in vitro and in vivo. MiR-126 downregulation in CF bronchial epithelial cells correlated with a significant upregulation of TOM1 mRNA, both in vitro and in vivo when compared with their non-CF counterparts. Introduction of synthetic pre–miR-126 inhibited luciferase activity in a reporter system containing the full length 3′-untranslated region of TOM1 and resulted in decreased TOM1 protein production in CF bronchial epithelial cells. Following stimulation with LPS or IL-1β, overexpression of TOM1 was found to downregulate NF-κB luciferase activity. Conversely, TOM1 knockdown resulted in a significant increase in NF-κB regulated IL-8 secretion. These data show that miR-126 is differentially regulated in CF versus non-CF airway epithelial cells and that TOM1 is a miR-126 target that may have an important role in regulating innate immune responses in the CF lung. To our knowledge, this study is the first to report of a role for TOM1 in the TLR2/4 signaling pathways and the first to describe microRNA involvement in CF.

[1]  B. Rubin,et al.  TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. , 2010, American journal of respiratory cell and molecular biology.

[2]  Bo Liu,et al.  MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. , 2009, Lung cancer.

[3]  M. Lindsay,et al.  microRNAs and the immune response. , 2008, Trends in immunology.

[4]  Frank Speleman,et al.  A novel and universal method for microRNA RT-qPCR data normalization , 2009, Genome Biology.

[5]  W. Ritchie,et al.  Predicting microRNA targets and functions: traps for the unwary , 2009, Nature Methods.

[6]  J. Friedman,et al.  Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. , 2009, Biochemical and biophysical research communications.

[7]  Thomas D. Schmittgen,et al.  Integrating the MicroRNome into the study of lung disease. , 2009, American journal of respiratory and critical care medicine.

[8]  Duan Ma,et al.  The cell growth suppressor, mir-126, targets IRS-1. , 2008, Biochemical and biophysical research communications.

[9]  Pieter Mestdagh,et al.  High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA , 2008, Nucleic acids research.

[10]  G. Nuovo,et al.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. , 2008, Biochemical and biophysical research communications.

[11]  M. David,et al.  MicroRNAs in the immune response. , 2008, Cytokine.

[12]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[13]  John McAnally,et al.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.

[14]  Ryan M. O’Connell,et al.  MicroRNAs: new regulators of immune cell development and function , 2008, Nature Immunology.

[15]  Randal J. Kaufman,et al.  From endoplasmic-reticulum stress to the inflammatory response , 2008, Nature.

[16]  M. Lindsay,et al.  Rapid Changes in MicroRNA-146a Expression Negatively Regulate the IL-1β-Induced Inflammatory Response in Human Lung Alveolar Epithelial Cells1 , 2008, The Journal of Immunology.

[17]  Jidong Liu,et al.  Control of protein synthesis and mRNA degradation by microRNAs. , 2008, Current opinion in cell biology.

[18]  A. Pivarcsi,et al.  MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. , 2008, Seminars in cancer biology.

[19]  H. Lodish,et al.  Micromanagement of the immune system by microRNAs , 2008, Nature Reviews Immunology.

[20]  Joshua T. Mendell,et al.  MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.

[21]  W. Filipowicz,et al.  Molecular biology: The expanding world of small RNAs , 2008, Nature.

[22]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[23]  G. Nuovo,et al.  Experimental validation of miRNA targets. , 2008, Methods.

[24]  R. Stallings,et al.  MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells , 2007, Oncogene.

[25]  P. Janson,et al.  MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis? , 2007, PloS one.

[26]  Anton J. Enright,et al.  Requirement of bic/microRNA-155 for Normal Immune Function , 2007, Science.

[27]  Mark M. Davis,et al.  miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection , 2007, Cell.

[28]  D. Baltimore,et al.  MicroRNAs and immunity: tiny players in a big field. , 2007, Immunity.

[29]  R. Stallings,et al.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. , 2007, Cancer research.

[30]  Lin Liu,et al.  Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research , 2007, BMC Genomics.

[31]  F. Martinon,et al.  Intracellular Trafficking of Interleukin-1 Receptor I Requires Tollip , 2006, Current Biology.

[32]  Y. Akao,et al.  MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. , 2006, Oncology reports.

[33]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[34]  Yohei Katoh,et al.  Recruitment of clathrin onto endosomes by the Tom1-Tollip complex. , 2006, Biochemical and biophysical research communications.

[35]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Bowie,et al.  Viral Inhibition of IL-1- and Neutrophil Elastase-Induced Inflammatory Responses in Bronchial Epithelial Cells1 , 2005, The Journal of Immunology.

[37]  D. Bartel,et al.  Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. , 2005, RNA.

[38]  N. McElvaney,et al.  TLR-Induced Inflammation in Cystic Fibrosis and Non-Cystic Fibrosis Airway Epithelial Cells1 , 2005, The Journal of Immunology.

[39]  Q. Hamid,et al.  Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis. , 2005, Canadian respiratory journal.

[40]  K. Nakayama,et al.  Tollip and Tom1 Form a Complex and Recruit Ubiquitin-conjugated Proteins onto Early Endosomes* , 2004, Journal of Biological Chemistry.

[41]  H. Yokosawa,et al.  Tom1 (target of Myb 1) is a novel negative regulator of interleukin-1- and tumor necrosis factor-induced signaling pathways. , 2004, Biological & pharmaceutical bulletin.

[42]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[43]  H. Yokosawa,et al.  Tom1, a VHS Domain-containing Protein, Interacts with Tollip, Ubiquitin, and Clathrin* , 2003, Journal of Biological Chemistry.

[44]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[45]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.